What are the Challenges and Limitations of NCI-MATCH?
While NCI-MATCH holds great promise, it also faces several challenges. One significant challenge is the heterogeneity of cancer, meaning that genetic mutations can vary widely even within the same type of cancer. This variability can complicate the identification of suitable targeted therapies. Additionally, the development and validation of new therapies can be time-consuming and costly. Despite these challenges, NCI-MATCH continues to advance the field of precision oncology.
